Skip to Content
Merck

Evidence for an intermediate conformational state of LacY.

Proceedings of the National Academy of Sciences of the United States of America (2012-02-23)
Xiaoxu Jiang, Lan Guan, Yonggang Zhou, Wen-Xu Hong, Qinghai Zhang, H Ronald Kaback
ABSTRACT

LacY mutant Cys154 → Gly exhibits a periplasmic-closed crystal structure identical to the WT, but is periplasmic-open in the membrane. The mutant hardly catalyzes transport, but binds galactosides from either side of the membrane with the same affinity and is resistant to site-directed proteolysis relative to the pseudo-WT. Site-directed alkylation was also applied to 11 single-Cys mutants in Cys154 → Gly LacY in right-side-out membrane vesicles or after solubilization and purification in dodecyl-β-D-maltopyranoside (DDM). Unlike the pseudo-WT, Cys replacements on the periplasmic side of the Cys154 → Gly mutant label rapidly in the membrane without sugar, but labeling decreases markedly after the mutant proteins are purified. Thus, Cys154 → Gly LacY likely favors a higher-energy intermediate periplasmic-open conformation in situ, but collapses to a lower-energy periplasmic-closed conformation in DDM after purification. Notably, branched-chain or neopentyl glycol maltoside detergents stabilize Cys154 → Gly LacY in the membrane-embedded form.

MATERIALS
Product Number
Brand
Product Description

Avanti
Mal(11.2), tridecan-3-yloxy-β-D-maltoside, powder
Avanti
n-dodecyl-β-D-maltoside (DDM), Avanti Research - A Croda Brand